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one morphogenetic protein 7 (BMP-7) regulates cel-
lular metabolism in embryonic and adult tissues.
Signal transduction occurs through the activation of
intracellular Smad proteins. In this paper, using a yeast
two-hybrid screen, Smad1 was found to interact with the
cytoplasmic domain of CD44, a receptor for the extracellu-
lar matrix macromolecule hyaluronan. Coimmunoprecipi-
tation experiments conﬁrmed the interaction of Smad1
with full-length CD44—interactions that did not occur
when CD44 receptors truncated within the cytoplasmic
domain were tested. Chondrocytes overexpressing a trun-
B
 
cated CD44 on a background of endogenous full-length
CD44 no longer exhibited Smad1 nuclear translocation
upon BMP-7 stimulation. Further, pretreatment of chondro-
cytes with 
 
Streptomyces
 
 hyaluronidase to disrupt extracellu-
lar hyaluronan–cell interactions inhibited BMP-7–mediated
Smad1 phosphorylation, nuclear translocation of Smad1 or
Smad4, and SBE4–luciferase reporter activation. These re-
sults support a functional link between the BMP signaling
cascade and CD44. Thus, changes in hyaluronan–cell in-
teractions may serve as a means to modulate cellular re-
sponsiveness to BMP.
 
Introduction
 
Bone morphogenetic proteins (BMPs) are members of the
TGF-
 
 
 
 superfamily. The inductive capacity of BMPs in tis-
sue development, regeneration, and repair as well as their ap-
plication in tissue engineering is so widespread that BMPs
have been referred to as “body morphogenetic proteins”
(Reddi, 1998). The actions of BMPs depend on concentra-
tion and on combination with a variety of other factors or
ECM components, as well as cell type or cellular age
(Hoffman and Gross, 2001). During chondrogenesis, the
interactions of cells with other components of the dynamic
three-dimensional ECM together with BMP signaling ini-
tiate chondrocyte differentiation.
Signaling by BMPs is initiated by their binding to serine/
threonine kinase type II and type I receptors and subsequent
activation of receptor-activated (R-) Smad proteins (Mous-
takas et al., 2001). The signaling pathway of BMP-7 (also
known as osteogenic protein-1) consists of a principal type
II receptor (ActR-II) that recruits and transphosphorylates
the type I receptor ALK2 (Macias-Silva et al., 1998). The
ALK2 receptor signals through the R-Smad Smad1. Phos-
phorylation of Smad1 leads to its dissociation from the type
I receptor and the subsequent oligomerization of Smad1
with the comediator Smad4 for nuclear translocation. This
signaling pathway is similar to that of BMP-2 and BMP-4
whereby after binding to BMPR-II, the type I receptor
ALK3 or ALK6 activate the Smad1 pathway. TGF
 
 
 
R-I and
TGF
 
 
 
R-II transduce TGF-
 
 
 
 responses through Smad2 and
Smad3, two related R-Smads (Moustakas et al., 2001).
Exogenous BMP-7 induces an anabolic response in a vari-
ety of connective tissues, including cartilage. BMP-7 stimu-
lates synthesis of aggrecan (the chief proteoglycan of cartilage)
and type II collagen (Flechtenmacher et al., 1996) as well as
CD44 and hyaluronan synthase-2 (Nishida et al., 2000a,b)
in bovine and human articular chondrocytes. Endogenous
BMP-7 expression is highest in the cell clusters in osteoar-
thritic cartilage (Chubinskaya et al., 2000)—areas that may
represent attempted repair. Thus, BMP-7 may regulate
cartilage development as well as articular cartilage repair and
 
R.S. Peterson and R.A. Andhare contributed equally to this paper.
Address correspondence to Cheryl B. Knudson, Dept. of Biochemistry,
Rush Medical College, Rush University Medical Center, 1653 West
Congress Parkway, Chicago, IL 60612. Tel.: (312) 942-8249. Fax: (312)
942-3053. email: cheryl_knudson@rush.edu
Key words: CD44; bone morphogenetic protein; hyaluronan; chondro-
cyte; Smad1
 
Abbreviations used in this paper: BMP, bone morphogenetic protein;
SBE, Smad-binding element. 
1082 The Journal of Cell Biology 
 
|
 
 
 
Volume 166, Number 7, 2004
 
homeostasis not only by its stimulation of the synthesis of
the major cartilage ECM components, but also with two
molecules necessary for the retention of aggrecan, namely
hyaluronan and CD44.
As with other tissues, cell–matrix interactions mediated
via transmembrane receptors are responsible for maintaining
cartilage homeostasis (Knudson and Knudson, 1993; Knud-
son, 2003). Articular chondrocytes express integrin as well as
nonintegrin ECM receptors (Knudson and Loeser, 2002).
These receptors, through interactions with their principal
ligands, provide chondrocytes the means to “sense” changes
in the ECM environment—changes that may elicit a repara-
tive response, matrix remodeling, or alternatively, cellular
quiescence. The CD44 receptor serves as the primary recep-
tor for the ECM macromolecule hyaluronan (Underhill,
1992), mediating both cell–cell and cell–matrix interactions.
The CD44H (“hematopoetic”) isoform is a highly glyco-
sylated type I receptor with a 72-aa cytoplasmic domain en-
coded by exon 20 (Screaton et al., 1992). The mRNA for
CD44E (“epithelial”) contains three additional exons (vari-
ants 8, 9, and 10) encoding additional protein motifs in the
extracellular domain and the same exon 20 encoding the cy-
toplasmic domain. CD44H is expressed by chondrocytes. In
limb development, modulation of hyaluronan–cell interac-
tions during chondrogenic condensation parallels the initia-
tion of CD44 expression (Knudson and Toole, 1987; Rousche
and Knudson, 2002). In adult articular chondrocytes, CD44
serves as the critical link to retain hyaluronan–proteoglycan
aggregates to the chondrocyte cell surface (Chow et al.,
1995). However, new evidence indicates that CD44 partici-
pates in the transduction of matrix cues.
In this work, a yeast two-hybrid screen was used to iden-
tify proteins that could potentially mediate CD44 signaling.
The screen detected binding between the Smad1 protein
and a full-length cytoplasmic domain construct of CD44.
CD44–Smad1 receptor interactions were confirmed by im-
munoprecipitations of cell lysates. CD44 receptors trun-
cated in the COOH-terminal cytoplasmic domain (Fig. 1 A)
did not have the capacity to interact with Smad1. Chondro-
cytes overexpressing truncated CD44 in the background of
endogenous full-length CD44 no longer exhibited Smad1
nuclear translocation upon BMP-7 stimulation, indicative of
a dominant-negative function. Additional evidence is pre-
sented to support that hyaluronan–CD44 binding augments
the cellular response to BMP-7, including Smad1 phosphor-
ylation and induced nuclear translocation of Smad1 and
Smad4. The chondrocyte response to matrix disruption or
damage is likely mediated by cross-talk between receptors to
ECM components and BMPs (Reddi, 1998). Thus, our data
provide further support for the emerging paradigm that cell–
matrix interactions modulate the cellular response to mor-
phogens or growth factors.
 
Results
 
Smad1 and CD44 cytoplasmic domain interaction 
detected by yeast two-hybrid analysis
 
Yeast two-hybrid analysis was performed to determine novel
proteins interacting with the cytoplasmic domain of CD44.
Two CD44 baits were developed, one representing the en-
Figure 1. Human CD44 cytoplasmic domain and CD44 expres-
sion by COS-7 and chondrocyte transfectants. (A) The amino acid 
sequence of the two yeast two-hybrid baits encoding CD44wt 
(aa 292–361; full-length CD44 cytoplasmic domain) and CD44 54 
(aa 292–307; truncation mutant CD44) are depicted. The truncated 
human CD44 mutants were generated by the introduction of a stop 
codon at Gly 308 for CD44 54 or at Cys 295 for CD44 67 in 
pCD44H. By immunocytochemistry, the CD44 extracellular epitope 
recognized by the BU-52 mAb was detected at the plasma mem-
brane of GFP-positive COS-7 cells transfected with pCD44H (B), 
pCD44E (C), and pCD44H 67 (E). The V5 epitope was detected af-
ter cell permeabilization of COS-7 cells transfected with pCD44H/
V5 (D). No positive reaction was observed in the nontransfected 
COS-7 cells (DAPI nuclear counterstain) in the same fields. After 
electrophoresis of equivalent protein aliquots from total cell lysates 
and electroblot transfer, CD44 isoforms expressed by transfected 
COS-7 cells were visualized with BU-52 (F). Nontransfected COS-7 
cells do not express CD44 (lane 1), but after transfection with 
pCD44H do express a characteristic diffuse band at  85 kD (lane 
2), faster migrating bands after transfection with pCD44H 67 (lane 
3) or pCD44H 54 (lane 4), or a fairly broad band at  130 kD after 
transfection with pCD44E (lane 5). Mol wt standards are in lane 6. 
After transfection with pCD44H 67, bovine chondrocytes now ex-
press GFP and cell surface human CD44 recognized by the BU-52 
mAb (G), whereas no BU-52 immunoreactivity was observed in 
nontransfected bovine chondrocytes (H). All bars, 20  m. 
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tire cytoplasmic domain and another a COOH-terminal
truncated version in which the distal 54 amino acids were
deleted, CD44
 
 
 
54 (Fig. 1 A). Both constructs were ex-
pressed to comparable levels in yeast. The yeast two-hybrid
analysis revealed an interaction of Smad1 with the full-
length cytoplasmic domain of CD44. An interactor match-
ing aa 110–225 of the Smad1 protein was identified upon
screening a prey library using the full-length CD44 cytoplas-
mic tail (aa 292–361) as bait, but not when the shorter
CD44
 
 
 
54 was tested (aa 292–307). The 
 
 
 
-galactosidase
score for the CD44–Smad1 interaction hit was recorded at
2.4 SDs above background. No interaction was observed
with any other Smad proteins previously characterized in the
prey libraries, namely Smads 3, 4, 8, and 9. Subsequently,
the full-length cytoplasmic domain bait was tested one-on-
one with Smad1 and the original hit was confirmed.
 
Expression of CD44 constructs transfected into COS-7 
cells and chondrocytes
 
Two model systems were used in this paper, COS-7 cells
that do not express CD44 and bovine articular chondro-
cytes—cells that express CD44 and exhibit an extensive
hyaluronan-dependent matrix. The anti-CD44 mAb
BU-52 recognizes an extracellular epitope present in human
CD44H and CD44E, as well as the COOH-terminal trun-
cation mutants CD44H
 
 
 
54 and CD44H
 
 
 
67 (Fig. 1 A). As
shown in Fig. 1 B, nontransfected COS-7 cells (visualized as
blue DAPI-stained nuclei) do not exhibit cell surface immu-
nostaining for CD44. Upon transfection with full-length
human pCD44H (successfully transfected cells are GFP pos-
itive), the COS-7 transfectants now displayed prominent
cell surface immunostaining for CD44 with BU-52 (Fig. 1
B, red fluorescence). Transfection of COS-7 cells with other
isoforms, pCD44E (Fig. 1 C) and the truncation mutant
pCD44H
 
 
 
67 (Fig. 1 E), followed by BU-52 staining
demonstrated that recombinant receptors were successfully
processed and transported to the plasma membrane. The
pCD44H/V5 construct, containing a COOH-terminal V5-
epitope tag, could be detected after cell permeabilization us-
ing an anti-V5 mAb (Fig. 1 D). By Western blot analysis of
total cell lysates (Fig. 1 F) we confirmed that nontransfected
COS-7 cells (lane 1) do not express CD44, as reported in
our previous paper (Jiang et al., 2002). Lysates from COS-7
cells transfected with pCD44H exhibited an immunoreac-
tive band at 
 
 
 
85 kD (lane 2), which is the signature molec-
ular mass of full-length, highly glycosylated CD44H. Ly-
sates from COS-7 cells transfected with the larger pCD44E
construct exhibited, as expected, a fairly broad band at
 
 
 
130 kD (lane 5). Lysates from cells transfected with the
COOH-terminal truncation mutants pCD44H
 
 
 
67 (lane 3)
or pCD44H
 
 
 
54 (lane 4) also exhibited protein bands of the
expected size range. Thus, in the COS-7 model the expres-
sion of CD44 can be selectively and specifically modified.
Primary cultures of bovine chondrocytes represent a more
biologically relevant model system. In these cells, transfection
of a COOH-terminal truncation mutant pCD44H
 
 
 
67 is
used as a dominant-negative to suppress the activity of the en-
dogenous full-length CD44 (Jiang et al., 2002). Successfully
transfected bovine chondrocytes can be visualized readily as
GFP-positive cells. In addition, processing and transport of
the human CD44H
 
 
 
67 to the plasma membrane in these
cells can be visualized by BU-52 immunostaining (Fig. 1 G,
red fluorescence). Bovine chondrocytes express abundant
CD44, but are not recognized by anti–human CD44 anti-
bodies such as BU-52 (Fig. 1 H; Aguiar et al., 1999).
 
Coimmunoprecipitation of CD44 and Smad1
 
The interaction between CD44 and Smad1 was con-
firmed by coimmunoprecipitation assays. COS-7 cells were
cotransfected with myc-tagged pSmad1 together with
pCD44H or pCD44H
 
 
 
67. The cells were lysed and pro-
teins were immunoprecipitated using an anti-myc antibody
followed by Western blotting with anti-CD44 or anti-Smad
mAb. Immunoprecipitation of Smad1 resulted in the copre-
cipitation of CD44H (Fig. 2 A, lane 1). The COOH-termi-
nal truncation mutant CD44H
 
 
 
67 was used as a control
and displayed no coprecipitation with Smad1 (Fig. 2 A,
lane 2). To confirm that CD44H and CD44H
 
 
 
67 were
present in the two cell lysates, the immunoprecipitation su-
pernatants were analyzed. As shown in Fig. 2 A, nearly
equivalent levels of CD44H (lane 4) and CD44H
 
 
 
67 (lane
5) were present in the original cell lysates. To address
Figure 2. Coimmunoprecipitation of CD44 and myc-Smad1. COS-7 
cells cotransfected with pSmad1/myc together with pCD44H, 
pCD44H 54, or pCD44H 67 were lysed, followed by immunopre-
cipitation using the anti-myc antibody. (A) Immunoprecipitation of 
Smad1 resulted in the coprecipitation of CD44H (lane 1), but not 
CD44H 67 (lane 2) detected with the anti-CD44 mAb BU-52. The 
supernatants after immunoprecipitation contained nearly equivalent 
levels of CD44H (lane 4) or CD44H 67 (lane 5). Mol wt standards 
are in lane 3. (B) The same blot from A (note that the air bubble 
watermark in both panels is useful for alignment) was reprobed with 
an anti-Smad1 antibody to confirm the myc-Smad1 immunoprecipi-
tation. Both lanes 1 and 2 contain Smad1 detected as bands of  55 
kD. (C) COS-7 cells cotransfected with pSmad1/myc together with 
pCD44H or pCD44H 54 were treated with BMP-7 for 60 min or 
left untreated before cell lysis. Immunoprecipitation of mycSmad1 
resulted in the coprecipitation of CD44H (lane 1). A 42% decrease 
in the band intensity for CD44H was observed (lane 2) when the 
lysates were prepared from transfectants pretreated with BMP-7. 
There was no coimmunoprecipitation of Smad 1 and CD44H 54 
(lane 3). The supernatants from these three immunoprecipitations 
were probed and showed similar high levels of expression of CD44H 
without (lane 5) or after BMP-7 treatment (lane 6) or expression of 
CD44H 54 (lane 7). Mol wt standards are in lane 4. 
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whether both lysates contained equal concentrations of
Smad1, the same immunoprecipitate blot (Fig. 2 A) was re-
probed with an anti-Smad1 antibody. As shown in Fig. 2 B,
lanes 1 and 2, the anti-myc antibody immunoprecipitated
nearly equal levels of myc-tagged Smad1, which can be seen
as bands of 
 
 
 
55 kD. Thus, immunoprecipitation of myc-
Smad1 resulted in the coprecipitation of CD44H. How-
ever, under the same conditions there was no coprecipita-
tion of the CD44 isoform CD44H
 
 
 
67 in which most of
the cytoplasmic domain has been eliminated.
To determine the effect of BMP-7 stimulation on
CD44-Smad1 interactions, COS-7 cells cotransfected with
pSmad1/myc together with pCD44H were incubated with-
out or with BMP-7 for 60 min. Again, immunoprecipita-
tion of Smad1/myc with the anti-myc antibody resulted in
the coprecipitation of CD44H (Fig. 2 C, lane 1). The
amount of CD44H that coprecipitated with Smad1/myc
decreased by 42% after pretreatment of the cells with BMP-7
(Fig. 2 C, lane 2). In this same experiment, immunopre-
cipitation was performed on lysates of COS-7 cells co-
transfected with Smad1/myc together with the other
COOH-terminal truncation mutant, CD44H
 
 
 
54. Corrob-
orating the yeast two-hybrid result, the CD44H
 
 
 
54 dis-
played no coprecipitation with Smad1 (Fig. 2 C, lane 3).
Again, to confirm the anti-myc immunoprecipitation the
same blot was reprobed using an anti-Smad1 antibody, and
all three lanes were found to contain equivalent levels of
Smad1 (unpublished data). In addition, analysis of the su-
pernatants from these three immunoprecipitations docu-
mented that each lysate contained similar amounts of
CD44H without (lane 5) or with BMP-7 pretreatment
(lane 6), or CD44H
 
 
 
54 (lane 7). Thus, immunoprecipita-
tion of Smad1 resulted in the coprecipitation of CD44H,
but not the CD44 cytoplasmic domain truncation mutants
(CD44H
 
 
 
54 and CD44H
 
 
 
67) when all three were ex-
pressed to similar extents in COS-7 cells. In addition, the
binding of BMP-7 to its receptor appeared to reduce the
level of CD44–Smad1 complexes.
To confirm the interaction of CD44 with endogenous
Smad1, COS-7 cells were transfected with pCD44 iso-
forms containing a V5-epitope tag. COS-7 cells expressing
CD44H/V5, CD44E/V5, or empty vector (pTracer-V5)
were lysed and immunoprecipitated using an anti-V5 mAb.
The immunoprecipitates were split into two aliquots and
were resolved by SDS-PAGE followed by electroblotting. In
Fig. 3, the top panel depicts the detection of Smad1 with
anti-Smad1 antibody and the bottom panel the detection of
CD44 with an anti-CD44 pAb. Lane 1 displays recombi-
nant Smad1 as a molecular weight marker (top blot) and as
molecular weight markers in the bottom blot. As shown in
lane 2, COS-7 cells transfected with empty vector displayed
no coprecipitation of endogenous Smad1. However, the
cells transfected with either CD44H (lane 3) and the larger
CD44E (lane 4) both displayed coprecipitation of endoge-
nous Smad1. The CD44E contains an identical intracellular
domain as CD44H, but has a longer extracellular domain
sequence. To confirm the immunoprecipitations, the pre-
cipitated lysates were probed on a separate blot using an
anti-CD44 antibody. From control COS-7 cells (Fig. 3, lane
2, bottom), only a nonspecific band at 124 kD was ob-
served. Lysates from COS-7 cells transfected with CD44H
exhibited an 
 
 
 
85-kD band as well as the nonspecific band
(lane 3, bottom), and CD44E-transfected cells, a wide band
at 
 
 
 
130 kD (lane 4, bottom). These CD44–Smad1 co-
immunoprecipitations confirm that endogenous Smad1
present in a mammalian cell type can form interactions with
two of the common CD44 isoforms, CD44H and CD44E.
Figure 3. Coimmunoprecipitation of 
CD44/V5 and endogenous Smad1. Af-
ter transfection of COS-7 cells with the 
control vector (pTracer-EF/V5-His), or 
with pCD44H/V5 or pCD44E/V5, cell 
lysates were immunoprecipitated with 
the anti-V5 mAb, and the immunoblots 
reacted with an anti-Smad1 (top) or 
anti-CD44 (bottom) polyclonal H-300 
antibody. On the top, endogenous 
Smad1 at  55 kD (compared with a Smad1 standard in lane 1) was 
identified from immunoprecipitates of CD44H (lane 3) and CD44E 
(lane 4) transfectants, but not from vector control COS-7 cells (lane 
2). From the second aliquot of the V5-immunoprecipitate, on the 
bottom, broad bands were detected at  85 and at  130 kD, corre-
sponding to the molecular mass of CD44H (lane 3) and CD44E 
(lane 4), respectively. Mol wt standards are in lane 1. No CD44 
epitope was detected in lysates from COS-7 vector-only controls 
(lane 2), only the sharp nonspecific band at 124 kD common to all 
lanes. These CD44–Smad1 coimmunoprecipitations confirm the in-
teraction of CD44H and CD44E with endogenous Smad1.
Figure 4. Resting CD44
  COS-7 transfectants show Smad1 cyto-
plasmic sequestration; BMP-7 treatment initiates Smad1 nuclear 
translocation. Parental COS-7 cells, which lack CD44 expression, 
exhibit diffuse staining of Smad1 protein (red fluorescence) through-
out the cytoplasm and the nucleus (A). No change in the diffuse 
staining pattern of Smad1 protein was observed in parental COS-7 
cells after treatment with BMP-7 (B). Stable COS-7 transfectants, 
expressing cell surface CD44, exhibited Smad1 immunolocalization 
preferentially to the cytoplasm, and Smad1 staining was nearly 
absent from the nucleus (C). After treatment of the CD44
  COS-7 
transfectants with BMP-7, the nuclear translocation of Smad1 protein 
was observed (D). Insets in all panels show two-color fluorescence 
with the DAPI nuclear stain of the same cells at lower magnification. 
Bar, 20  m for the main panels. 
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Nuclear translocation of endogenous Smad1 in COS-7 
transfectants expressing CD44
 
To address whether CD44–Smad1 interactions are impor-
tant in situ, a cell-based, functional approach was investi-
gated. Because nuclear translocation of R-Smad proteins is
one of the cellular responses to BMP stimulation, we exam-
ined whether changes in the cellular localization of Smad1
were modulated by the expression of CD44. COS-7 cells in
suspension were incubated 
 
 
 
 BMP-7. Parental COS-7 cells,
which lack CD44 expression, exhibited diffuse staining of
endogenous Smad1 protein throughout the cytoplasm and
the nucleus (Fig. 4 A). This is in agreement with a previous
report that Smad1 shuttles between these compartments in
a resting cell (Xiao et al., 2001). Surprisingly, parental
COS-7 cells showed no change in the diffuse staining pat-
tern of Smad1 after incubation with BMP-7 (Fig. 4 B), al-
though nuclear translocation could still be occurring to
some extent. This pattern differed considerably from that of
a stable CD44
 
 
 
 transfectant clone of COS-7 cells. Nonstimu-
lated CD44
 
 
 
 COS-7 cells exhibited endogenous Smad1 im-
munolocalization predominantly in the cytoplasm with
little to no nuclear localization (Fig. 4 C). These results sug-
gest a role for CD44 in Smad1 cytoplasmic sequestration or
for presentation to BMP receptors. When the CD44
 
 
 
COS-7 transfectants were treated with BMP-7, a clear trans-
location of endogenous Smad1 protein to the nucleus was
observed (Fig. 4 D). The overlayed position of DAPI-
stained nuclei are shown in the insets. Thus, upon BMP-7
stimulation of COS-7 transfectants expressing CD44, en-
dogenous Smad1 translocated from the cytoplasm to the
nucleus. These data suggest that expression of functional
CD44 may be required for the nuclear translocation of
Smad1 after BMP-7 stimulation.
 
Inhibition of functional CD44
 
Next, a loss-of-function approach was used to validate the
physiological significance of CD44–Smad1 interactions in
situ. For these experiments we investigated Smad1 and
Smad4 translocation in primary cultures of bovine articular
chondrocytes. As shown in Fig. 5 (A and B) control, non-
stimulated bovine chondrocytes exhibited cytoplasmic lo-
calization of Smad1 (red fluorescence). Upon 60 min of
stimulation with BMP-7, nuclear translocation of Smad1 is
observed (Fig. 5, C and D). Previous experiments in our lab-
oratories demonstrated that CD44H
 
 
 
67 transfectants can
neither bind nor internalize extracellular hyaluronan (Jiang
et al., 2002). Furthermore, overexpression of this isoform in
bovine articular chondrocytes results in a dominant-nega-
tive effect, inhibiting the biological activity of the endog-
enous, bovine 85-kD CD44 (Jiang et al., 2002). Bovine
chondrocyte cultures were transiently transfected with
pCD44H
 
 
 
67, and transfection was monitored with the co-
expression of GFP by chondrocytes within the cultures. In
the field depicted in Fig. 5 (E and F), there is one GFP
 
 
 
 cell
(arrow) adjacent to four nontransfected chondrocytes. After
treatment with BMP-7 for 60 min, all of the GFP-negative
control chondrocytes display Smad-1 nuclear translocation
similar to those cells depicted in Fig. 5, C and D. However,
the transfected chondrocytes overexpressing dominant-nega-
tive CD44H
 
 
 
67 (Fig. 5, E and F; GFP
 
 
 
 cell, arrow) exhib-
ited no nuclear staining for endogenous Smad1 and retained
the cytoplasmic localization of Smad1, similar to nonstimu-
lated chondrocytes. As a control, the full-length CD44H
construct was overexpressed in bovine chondrocytes, and
this did not inhibit Smad1 nuclear translocation in response
to BMP-7 (unpublished data). These results were further
validated using the other COOH-terminal truncation mu-
tant, CD44H
 
 
 
54 (see Fig. 1 A). This isoform differs from
CD44H
 
 
 
67 in that it does have the capacity to bind hy-
aluronan, but is insufficient capacity to interact with Smad1
(as shown in the yeast two-hybrid and immunoprecipitation
experiments). As such, overexpression of this construct will
not interfere with cell–matrix interactions, but should block
intracellular CD44 interactions. As with the transfection of
chondrocytes with CD44H
 
 
 
67, chondrocytes expressing
CD44H
 
 
 
54 did not exhibit nuclear staining for Smad1 af-
ter BMP-7 treatment (Fig. 5, E and F, insets). Together, a
functional CD44 cytoplasmic domain, distal to the point of
the COOH-terminal CD44
 
 
 
54 truncation, appears to pro-
mote nuclear translocation of Smad1 after BMP-7 stimula-
tion of chondrocytes.
Figure 5. Expression of dnCD44 in bovine chondrocytes dimin-
ishes Smad1 nuclear translocation. A, C, and E show the three-
color overlay with Smad1 protein in red fluorescence, GFP, and 
DAPI, whereas the red only is shown in B, D, and F. Control articular 
chondrocytes exhibited diffuse staining of Smad1 protein in the 
cytoplasm (A and B). Upon BMP-7 treatment for 60 min, Smad1 
translocation to the nucleus was observed (C and D). Transfection of 
chondrocytes with pCD44H 67 (E and F, arrow) results in the coex-
pression of the GFP, but after BMP-7 treatment there was no nuclear 
staining for Smad1. However, Smad1 translocated to the nucleus of 
the nontransfected chondrocytes in the same field (E and F) after 
treatment BMP-7. Chondrocytes transfected with pCD44H 54 (E 
and F, inset) also lacked Smad1 nuclear translocation upon BMP-7 
treatment. Bars, 20  m. 
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Nuclear translocation of endogenous Smad1 and 
Smad4 in bovine articular chondrocytes
 
Next, we explored whether changes in cell–matrix interac-
tions that are mediated through CD44 modulate Smad1-
mediated signal transduction. Chondrocytes in culture as-
semble a prominent pericellular matrix that is anchored by
CD44–hyaluronan interactions (Knudson and Knudson,
1993; Knudson, 2003). Treatment with 
 
Streptomyces
 
 hy-
aluronidase specifically degrades hyaluronan and the peri-
cellular matrix of chondrocytes is removed. Thus, we
compared the responsiveness of matrix-intact and matrix-
depleted chondrocytes to treatment with BMP-7. BMP-7
responsiveness was first characterized by changes in the cellu-
lar distribution of Smad1 and Smad4 after 60 min of BMP-7
stimulation. Control, nonstimulated chondrocytes with an
intact pericellular matrix exhibited diffuse immunostaining
of Smad1 protein in the cytoplasm (Fig. 6 A). Upon BMP-7
stimulation of chondrocytes for 60 min, endogenous Smad1
translocation to the nucleus was clearly observed as bright
nuclear immunostaining (Fig. 6 B). However, in matrix-
depleted chondrocytes, subsequent treatment with BMP-7
did not result in Smad1 nuclear translocation (Fig. 6 D). These
matrix-depleted chondrocytes continued to exhibit the same
nonnuclear, diffuse cytoplasmic localization Smad1 as ob-
served in the nonstimulated chondrocytes (Fig. 6 C).
In Fig. 7, bovine chondrocytes depicted at lower magnifi-
cation were immunostained for either endogenous Smad1
(A, C, E, and G) or endogenous Smad4 (B, D, F, and H).
Control, matrix-intact chondrocytes exhibited diffuse stain-
ing for Smad1 (Fig. 7 A) and Smad4 (Fig. 7 B). After BMP-7
stimulation of matrix-intact chondrocytes, Smad1 translo-
cation to the nucleus (Fig. 7 C) and Smad4 translocation to
the nucleus (Fig. 7 D) was observed. 
 
Streptomyces
 
 hyaluroni-
dase pretreatment did not, per se, alter the staining patterns
observed for Smad1 (Fig. 7 E) or Smad4 (Fig. 7 F). How-
ever, after removal of the pericellular matrix with 
 
Streptomy-
ces
 
 hyaluronidase, subsequent treatment with BMP-7 no
longer elicited Smad1 (Fig. 7 G) or Smad4 (Fig. 7 H) nu-
clear translocation. These results suggest that CD44 receptor
occupancy with its ligand, hyaluronan, supports the func-
tional participation of CD44 in the activation of Smad1/4
in the BMP-7 signal transduction pathway.
Figure 6. Nuclear translocation of endogenous Smad1 in bovine 
chondrocytes. Smad1 was localized predominantly in the cytoplasm 
of matrix-intact chondrocytes, with little detectable nuclear immu-
nolocalization (A). After BMP-7 treatment of matrix-intact chondro-
cytes, Smad1 nuclear immunolocalization is predominant (B). After 
Streptomyces hyaluronidase treatment, immunostaining revealed 
the maintenance of the diffuse cytosolic location of Smad1 (C). 
However, BMP-7 treatment of Streptomyces hyaluronidase–pre-
treated chondrocytes did not result in nuclear translocation of 
Smad1 (D), as seen in the response to BMP-7 by matrix-intact chon-
drocytes. Bars, 20  m.
Figure 7. Nuclear translocation of Smad1 and Smad4 in bovine 
chondrocytes. Articular chondrocytes were immunostained (red) for 
either Smad1 (A, C, E, and G) or Smad4 (B, D, F, and H). Control, 
matrix-intact chondrocytes exhibit diffuse staining for Smad1 (A) 
and Smad4 (B). After BMP-7 stimulation of chondrocytes for 60 min, 
Smad1 (C) and Smad4 (D) translocation to the nucleus was observed; 
insets to these panels show the two-color overlay with DAPI nuclear 
staining and Smad1 or Smad4 protein. Streptomyces hyaluronidase 
pretreatment alone did not alter the staining patterns observed for 
Smad1 (E) or Smad4 (F). However, after removal of the pericellular 
matrix with Streptomyces hyaluronidase, subsequent treatment with 
BMP-7 no longer elicited Smad1 (G) or Smad4 (H) nuclear translo-
cation. Bars, 20  m. 
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Western blot analysis of Smad1 phosphorylation
 
Smad1 phosphorylation is an initial cellular response to
BMP-7 binding to its receptor. Thus, we examined whether
disruption of stable CD44–hyaluronan interactions would
reduce this response. Total cell lysates were prepared from
chondrocytes and were analyzed by SDS-PAGE and West-
ern blotting using anti-Smad1 (to detect total Smad1), anti-
 
 -actin, and anti-phospho-Smad1 antibodies (Fig. 8).
Lysates from control chondrocytes contained little phos-
pho-Smad1 (lane 1), but lysates from chondrocytes treated
for 60 min with 100 ng/ml BMP-7 showed a strong band
for phospho-Smad1 (lane 2). Treatment with Streptomyces
hyaluronidase alone did not change the intensity of the
band for phospho-Smad1 (lane 3) in nonstimulated cells
as compared with control (lane 1). However, Streptomyces
hyaluronidase treatment followed by addition of BMP-7
down-regulated phospho-Smad1 content (lane 4). Total
Smad1 in the lysates of chondrocytes from these four con-
ditions showed little variation; average band intensity for
the four conditions was 156.25   7.5 ODU/mm
2. Total
 -actin in these four lysates also showed little variation (Fig.
8, lanes 5–8); average band intensity for the four conditions
was 68.96   1.74 ODU/mm
2. Normalizing the band in-
tensity for each phospho-Smad1 band with the respective
 -actin band intensity was calculated to correct for slight
variations in protein concentration. Setting the ratio of
phospho-Smad1/ -actin in control lysates to 1.00, the fol-
lowing ratios were calculated for the other culture condi-
tions:  BMP-7   23.73;  Streptomyces hyaluronidase  
2.8;  Streptomyces hyaluronidase  BMP-7   10.55. These
results suggest that interfering with cellular interactions
with the hyaluronan-rich ECM reduces the resultant Smad1
phosphorylation in response to BMP-7 stimulation.
Protein/DNA array analysis of transcription factor 
activation after treatment with BMP-7
Next, we explored changes in transcription factor activation
induced by BMP-7 stimulation of bovine chondrocytes. Us-
ing protein/DNA array methodology, nuclear extracts of
chondrocytes were analyzed after BMP-7 stimulation with-
out or with pretreatment with Streptomyces hyaluronidase.
After BMP-7 stimulation for 60 min, many transcription
factors in the binding element sequence array remained un-
changed (and some undetectable) as compared with control,
nonstimulated cells. However, two relevant elements, Smad-
binding element (SBE; AGTATGTCTACACTGA) and the
Smad4 element sequence (containing three CAGACA re-
peats; Jonk et al., 1998), both showed increased hybridiza-
tion after BMP-7 treatment (Fig. 9). This increased hybrid-
ization represents increased DNA-binding activity of these
transcription factors. Pretreatment with Streptomyces hy-
aluronidase before BMP-7 treatment abated the increased
hybridization seen with BMP-7 treatment alone. Quantifi-
cation of the dots is shown in Table I. Pax-1 is shown as one
example of a transcription factor that showed no change in
activity with the treatments, whereas BMP-7 treatment up-
Figure 8. Western blot analysis of Smad1 phosphorylation. Total 
cell lysates were prepared from bovine articular chondrocytes and 
were analyzed by SDS-PAGE and Western blotting using anti-phos-
pho-Smad1 and anti- -actin antibodies. Lysates from control chon-
drocytes contained little phospho-Smad1 (lane1), but lysates from 
chondrocytes treated for 60 min with BMP-7 showed a strong band 
for phospho-Smad1 (lane 2). Treatment with Streptomyces hyaluron-
idase alone did not change the intensity of the band for phospho-
Smad1 (lane 3) as compared with control (lane 1). However, Strep-
tomyces hyaluronidase pretreatment followed by addition of BMP-7 
down-regulated phospho-Smad1 content (lane 4). Total  -actin in 
these four lysates showed little variation in band intensity for the 
four conditions (lanes 5–8), respectively.
Figure 9. Protein/DNA array analysis of transcription factor acti-
vation after treatment with BMP-7. Nuclear extracts isolated from 
bovine articular chondrocytes were analyzed for binding activity to 
oligonucleotides encoding SBEs (SBE and Smad4; sequences shown 
at top of figure). Each transcription factor is quantified in duplicate 
at 1  concentration (top two dots) and at 0.1  concentration (bot-
tom two dots). Control chondrocytes show resting levels of nuclear 
Smads. After BMP-7 stimulation for 60 min, chondrocyte nuclear 
extracts showed increased hybridization to both the Smad SBE and 
the Smad4 element. Pretreatment with Streptomyces hyaluronidase 
(S.H’ase) before BMP-7 treatment abated the increased hybridization 
seen with BMP-7 treatment alone.
Table I. Transcription factor activation following treatment of 
articular chondrocytes with BMP-7
Sample Smad4 SBE Pax-1
Control 111.1   1.2 2.4   0.9 53.8   0.7
 BMP-7 481.2   4.0 29.2   0.4 54.4   1.5
 BMP-7/ S.H’ase 217.7   11 20.8   1.4 53.6   0.9
Control 34.6   0.1 - -
S.H’ase 32.0   2.0 - -
Nuclei were isolated from control chondrocytes or after treatment with
BMP-7, Streptomyces hyaluronidase alone (S.H’ase), or co-treatment with
BMP-7 and S.H’ase. Transcription factor activation was determined as
hybridization signal intensity and presented as the mean   SEM.1088 The Journal of Cell Biology | Volume 166, Number 7, 2004
regulated Smad activity. Treatment with Streptomyces hyal-
uronidase alone did not change Smad activity in nonstimulated
chondrocytes. However, pretreatment with Streptomyces hyal-
uronidase reduced the BMP-7 stimulation of Smad DNA-
binding activity. These results confirm Smads as transcrip-
tion factors differentially activated due to BMP-7 treatment
of articular chondrocytes, and that this activation is dimin-
ished in matrix-depleted chondrocytes.
Analysis of an SBE reporter
Jonk et al. (1998) demonstrated enhanced luciferase activity
in response to TGF- , activin, and BMP-7 in HepG2 cells
transfected with a PGL3ti-(SBE)4 plasmid. The PGL3ti-
(SBE)4 contains a concatemerized CAGACA sequence. The
PGL3ti-(SBE)4 plasmid was well expressed after transfection
of the C28/I2 chondrocytes, and BMP-7 treatment resulted
in a stimulation of luciferase activity above controls (Fig.
10). However, the enhanced luciferase activity was blocked
by pretreatment with Streptomyces hyaluronidase before the
BMP-7 stimulation of chondrocytes (Fig. 10).
Discussion
In this work, we have uncovered an interaction between
CD44 and Smad1. Our data support a functional link be-
tween the BMP-7 signal transduction cascade and CD44,
and that CD44–hyaluronan interactions promote the cellular
response to BMP-7. Thus, modulation or disruption of hy-
aluronan–cell interactions—during development, tissue re-
modeling, or degeneration—may decrease the BMP respon-
siveness of that cell. Most cells express CD44, the principal
hyaluronan receptor, and display modified cellular behavior
after interaction with hyaluronan (Toole, 2004). Our results
suggest that CD44–hyaluronan interactions strengthen the
cellular response to BMP-7 that is initiated by Smad1 phos-
phorylation and nuclear translocation. The disruption of hy-
aluronan binding to CD44, either by Streptomyces hyaluroni-
dase treatment or overexpression of a dominant-negative
CD44H 67, resulted in diminished nuclear translocation of
endogenous Smad1 in response to BMP-7. A naturally oc-
curring CD44 isoform with a truncated cytoplasmic domain
is generated by alternative splicing of exon 19 in place of
exon 20 (Screaton et al., 1992). CD44exon19 is identical to
the recombinant CD44H 67. Interestingly, in a previous
paper, we demonstrated that normal human chondrocytes
express this CD44 “tail-less” splice variant in proportions
varying from 5 to 40% of the total CD44H mRNA (Jiang et
al., 2001). When present in the plasma membrane, this vari-
ant protein does not bind hyaluronan, would not bind
Smad1, and would likely reduce Smad1 nuclear translocation
in the BMP signal transduction cascade. Thus, up-regulation
of the CD44exon19 splice variant in vivo could be one
mechanism to decrease the cellular response to BMPs.
Our observations are consistent with a role for CD44-
Smad1 binding in the augmentation of the cellular response
to BMPs. CD44 could anchor Smad1 in resting cells for pre-
sentation to the type I BMP receptor. After BMP stimula-
tion, we observed a reduction in CD44-Smad1 coimmuno-
precipitation as nuclear translocation of Smad1 and Smad4
proceeded. As a precedent, other cytosolic molecules that
control the access of R-Smads to the activated type I recep-
tors have been described. Smad anchor for receptor activa-
tion (SARA) presents Smad2 or Smad3 to the activated
TGF  receptor complex. SARA binds to the MH2 domain
of Smad2, inducing a conformational change to increase
the efficiency of receptor-mediated Smad2 phosphorylation
(Wu et al., 2000). The phosphorylation releases Smad2/3
from SARA, allowing Smad4 binding and translocation to
the nucleus. As well, the actin-binding protein filamin was
found to be a Smad2-binding protein. Filamin-deficient
melanoma cells were defective in TGF  signaling, but tran-
sient expression of filamin restored the response of TGF -
reporter gene activation and Smad2 nuclear accumulation
(Sasaki et al., 2001). These investigators proposed that fil-
amin might serve as an anchor protein analogous to SARA,
to maintain localization of Smad2 near TGF  receptors or
to present Smad2 in a conformation to facilitate its phos-
phorylation. CD44 may function in an analogous manner.
Gain of CD44 expression in the COS-7 transfectants re-
sulted in both the more unambiguous cytoplasmic local-
ization of Smad1 in the resting transfectants and nuclear
translocation of endogenous Smad1 in response to BMP-7
stimulation.
Our current analyses provide additional insight into the
mechanism of Smad1 presentation to its cognate receptor
kinase as described in other models (Moustakas et al., 2001;
Qin et al., 2001). Our data suggest that the Smad1-binding
site in the CD44 cytoplasmic domain is distal to the point of
the CD44 54 truncation. Phosphorylation of serine resi-
dues in the cytoplasmic domain of CD44 can modulate re-
ceptor function (Lewis et al., 2001). The forkhead associated
(FHA) domain of Smad1 is a phosphopeptide-binding do-
main common to many proteins. Smad1-CD44 binding,
potentially via a FHA–phosphoserine interaction, could also
participate in the recruitment and/or presentation of Smad1
Figure 10. Analysis of an SBE reporter construct in chondrocytes. 
The PGL3ti-(SBE)4 construct was well expressed in untreated control 
C28I2 chondrocytes (C) compared with the empty PGL3 Basic. 
BMP-7 treatment resulted in a 2.1-fold stimulation of luciferase ac-
tivity. However, luciferase activity either decreased or remained the 
same upon treatment with Streptomyces hyaluronidase (S.H’ase) or 
with Streptomyces hyaluronidase pretreatment followed by BMP-7 
stimulation of chondrocytes. R.L.U., relative luminescence units; 
n.s., not significant, P   0.5; *, P   0.05 by t test.CD44 modulates Smad1 activation by BMP-7 | Peterson et al. 1089
to its type I receptor. Enzymatic removal of hyaluronan re-
duced CD44 phosphorylation (unpublished data), which
might diminish Smad1-CD44 binding.
Notch and CD44 are receptors without catalytic activity
in the cytoplasmic domain, but which undergo regulated in-
tramembrane proteolysis (Cichy and Pure, 2003; Thorne et
al., 2004). An extracellular domain cleavage followed by
 -secretase cleavage of the transmembrane domain releases the
Notch intracellular domain (ICD; De Strooper et al., 1999)
or the CD44 ICD (Lammich et al., 2002; Murakami et al.,
2003), which exhibit nuclear translocation. Our results im-
ply the capacity for Smad1 binding to the CD44 ICD. The
CD44 ICD can cooperate with the p300/CREB-binding
protein (CBP) to activate transcription (Okamoto et al.,
2001). Smad1 also acts with p300/CBP to regulate tran-
scriptional activation by BMPs (Pouponnot et al., 1998). In
light of these previous reports, our findings suggest that
Smad1 together with the CD44 ICD may function as acces-
sory modulators of transcriptional regulation.
The shedding of CD44 after MT1-MMP cleavage of the
extracellular domain has been proposed as a mechanism to
regulate cell detachment from hyaluronan (Kajita et al.,
2001). In addition to proteolytic cleavage of CD44, the re-
ceptor is internalized (Aguiar et al., 1999) as part of uptake of
hyaluronan to the lysosomal compartment (Knudson and
Knudson, 1993). The half-life of cell surface CD44 also de-
creases in the absence of its ligand, hyaluronan (Aguiar et al.,
1999). Together with reduction in CD44 phosphorylation in
the absence of ligand or increased expression of CD44exon19
as described above, all these are possible mechanisms to limit
the participation of CD44 in the BMP signaling pathway.
Our results indicate that the regulation of functional
CD44 and CD44 receptor ligation by hyaluronan influences
the physiological functions for CD44–Smad1 interaction to
modulate the cellular response to BMP-7. Thus, it is possi-
ble that changes in CD44–hyaluronan interactions during
embryogenesis may regulate the cellular response to BMP.
Stable CD44–hyaluronan binding maintains cartilage ho-
meostasis. Cartilage matrix disruption by interleukin-1 (Ay-
delotte et al., 1992) or fragments of the ECM (Chow et al.,
1995; Knudson et al., 2000) results in an imbalance between
ECM degradation and anabolic responses by chondrocytes.
The intersection of CD44 with the BMP signal transduction
pathways may explain this dysregulation. The evidence that
Smad1 interacts with the cytoplasmic domain of CD44 sup-
ports an emerging paradigm wherein changes in the ECM
can modulate BMP signal transduction, culminating in the
influence on cellular metabolism.
Materials and methods
Cell culture and transfection
Truncated CD44 mutants were generated by the introduction of stop
codons (Cys 295: TGT→TGA for  67; or Gly 308: GGA→TGA for  54) in
exon 20 of pCD44H (Fig. 1 A) using PCR-mediated site-directed mutagene-
sis as described previously (Jiang et al., 2002). CD44H, CD44H 67, and
CD44H 54 were subcloned into a GFP coexpression vector pTracer-SV40
(Invitrogen; Jiang et al., 2002). Additionally, hCD44H and hCD44E cDNAs
were subcloned into the pTracer-EF/V5-His vector (Invitrogen) so the result-
ant protein would contain a COOH-terminal V5 epitope tag recognized by
an anti-V5 mAb (Invitrogen). The parental COS-7 cells express Smad1, but
do not express CD44. COS-7 cells were transiently transfected with the var-
ious CD44 constructs using LipofectAMINE 2000 (Invitrogen) as described
previously (Jiang et al., 2002). After transfection with pCD44H, a stable
clone expressing cell surface CD44 and GFP was isolated using Zeocin se-
lection. After transfection, the anti–human CD44 mAb BU-52 (The Binding
Site), which recognizes an extracellular epitope in both CD44H and CD44E,
was used to confirm expression. COS-7 cells were also transiently trans-
fected with Smad1 subcloned into pcDNA3.1/myc-His (Invitrogen) or co-
transfected with pSmad1/myc and pCD44H, pCD44 67, or CD44H 54.
Bovine articular chondrocytes were isolated (Chow et al., 1995), cul-
tured for a short term in alginate beads (Nishida et al., 2000b), and then re-
leased and plated at 9   10
6 cells/100-mm dish as monolayer cultures in
DMEM   10% FBS overnight. For transfection, the chondrocytes were pre-
treated with 5 U/ml Streptomyces hyaluronidase (Sigma-Aldrich) in serum-
free DMEM. LipofectAMINE 2000 was incubated with pCD44H, pCD44H 67,
or pCD44H 54, or with the pTracer-SV40 empty vector (facilitator/DNA
ratio, 2.5:1), and lipid/DNA complexes were added at 15  g DNA/10
7
cells (Jiang et al., 2002). FBS was added 5 h after transfection to a final
concentration of 20%. 24 h after transfection, the medium was replaced
with DMEM   10% FBS and analysis began after 48 h. Transfected bovine
chondrocytes express GFP and the human CD44H (or CD44H 67 or
CD44H 54) protein at the cell surface as detected with BU-52 mAb.
Yeast two-hybrid screen
Two yeast two-hybrid baits were constructed by subcloning cDNAs en-
coding aa 292–361 (full-length CD44 cytoplasmic domain) and aa 292–
307 (CD44 54 COOH-terminal truncation) of the human CD44 receptor
into the DNA-binding domain fusion vector pMW101 (Watson et al.,
1996). The yeast two-hybrid screening protocol was performed as de-
scribed previously (Slentz-Kesler et al., 2000) using cDNA libraries derived
from human prostate and human macrophages.
Coimmunoprecipitation assays and Western blot analyses
48 h after transfection, the cells were lysed in 20 mM Tris, pH 7.4, with 50
mM NaCl, 5 mM EDTA, 3 mM MgCl2, 0.5% Triton-X-100 buffer, with pro-
tease (P2714, Sigma-Aldrich) and phosphatase inhibitors (P2850, Sigma-
Aldrich). The cell lysates were precleared by protein G–Sepharose (Zymed
Laboratories) followed by an overnight incubation at 4 C with anti-myc
antibody (Invitrogen) and protein G–Sepharose beads. The beads were
washed twice with lysis buffer and the immunoprecipitates were eluted us-
ing 100 mM glycine solution, pH 2.6, boiled for 10 min under reducing
conditions before loading for SDS-PAGE using a 10% Tris-HCl gel. PVDF
membrane was used in the electrotransfer. 5% milk in PBS-Tween was
used as a blocking solution. The blot was first probed for CD44 using bio-
tinylated BU-52 antibody (ID Labs), detected with Streptavidin-HRP and
ECL reagents (Amersham Biosciences). After 4 d soaking in water, the same
blot was next probed for Smad1 after the initial HRP-Streptavidin signal
had faded. The anti-Smad-1 pAb (Upstate Biotechnology) was detected us-
ing a Vectastain kit (Vector Labs), and incubation with HRP-Streptavidin
was followed by ECL reagents. Alternatively, COS-7 transfectants were
lysed in 50 mM Tris, pH 7.4, with 150 mM NaCl, 3 mM MgCl2, and 0.5%
NP-40 buffer, and with protease and phosphatase inhibitors. Pre-cleared
lysates were incubated with the anti-V5 mAb and protein G–Sepharose
overnight. The immunoprecipitates were analyzed by SDS-PAGE on a
7.5% gel followed by Western blotting. CD44 was detected with an anti-
CD44 pAb (H-300; Santa Cruz Biotechnology, Inc.) and endogenous
Smad1 was identified using the anti-Smad1 antibody.
Bovine chondrocytes were treated for 60 min with 100 ng/ml BMP-7
(R&D Systems) in the absence or presence of Streptomyces hyaluronidase
(5 U/ml, 90 min pretreatment followed by a second addition of enzyme at
the time of addition of BMP-7), or were left untreated. Total cell lysates
were prepared (with the 50 mM Tris buffer above) and analyzed by SDS-
PAGE on a 10% gel followed by Western blotting. Total Smad1 and phos-
phorylated Smad1 were detected with anti-Smad1 and anti-phospho-Smad1
pAbs, respectively (Upstate Biotechnology; Macias-Silva et al., 1998). Ac-
tin was detected by a  -actin peptide mAb (AC-15; Sigma-Aldrich).
The resultant band intensities were quantified using a Fluor-S imaging sys-
tem (Bio-Rad Laboratories).
Immunostaining and Smad nuclear translocation
COS-7 stable transfectants (CD44
 ), control chondrocytes, or chondro-
cytes after transfection were incubated overnight in media containing only
0.5% FBS. Cells were lifted with nonenzymatic cell dissociation solution
(Sigma-Aldrich), incubated for 60 min with 100 ng/ml BMP-7, and then
fixed with 2% PFA, permeabilized with 0.2% Triton X-100, and incubated
with an anti-Smad1 or an anti-Smad4 antibody (Upstate Biotechnology),
which were detected using rhodamine red-X goat anti–rabbit IgG (Jackson
ImmunoResearch Laboratories). Some chondrocytes were pretreated with1090 The Journal of Cell Biology | Volume 166, Number 7, 2004
Streptomyces hyaluronidase. All cells were incubated with DAPI (Molecu-
lar Probes, Inc.) as a nuclear counterstain. The cells were viewed using a
microscope (Ellipse E600; Nikon) equipped with Y-Fl Epi-fluorescence,
PLAN-Apochromat 1.4 NA/60  oil and PLAN 0.5 NA/20  objectives. Im-
ages were captured digitally in real time using a camera (Spot-RT; Diag-
nostic Instruments) and were processed using MetaView imaging software
(Universal Imaging Corp.).
Protein/DNA array analysis of transcription factor activation
Nuclear extracts isolated from bovine articular chondrocytes were treated
for 60 min with 100 ng/ml BMP-7, in the presence or absence Streptomy-
ces hyaluronidase, or untreated control chondrocytes were incubated with
biotinylated DNA oligonucleotides of 54 select transcription factor binding
element sequences (TransSignal Array; Panomics) (Lam and Li, 2002; Zeng
et al., 2003). After isolation of protein/DNA complexes, the samples were
denatured and retained binding elements hybridized to membranes con-
taining complementary sequences. Hybridized biotinylated oligonucle-
otides were visualized using ECL reagents. Each transcription factor was
quantified in duplicate at 1  concentration, and in duplicate at 0.1  con-
centration, per condition.
Stimulation of Smad-binding element promoter activity in 
chondrocyte by BMP-7
An SBE-driven luciferase reporter plasmid PGL3ti-(SBE)4 (Jonk et al., 1998;
Althini et al., 2003) was obtained from Dr. Bart Eggen (University of
Groningen, Groningen, Netherlands). The immortalized human chondro-
cyte C-28/I2 cells (Tan et al., 2003) were provided by Dr. Mary Goldring
(Harvard Institutes of Medicine, Boston, MA). For transfection, the cells
were plated 24 h before transfection at a density of 10
5 cells/well in 12-
well plates, cultured for 24 h, and transiently cotransfected in serum-free
media with 1  g of the PGL3ti-(SBE)4 with FuGENE 6 reagent (Roche). Af-
ter 24 h the media was changed to DMEM and 0.5% FBS. 48 h after trans-
fection, chondrocytes were treated for 24 h with 100 ng/ml BMP-7 in the
absence or presence of Streptomyces hyaluronidase (5 U/ml, 2-h pretreat-
ment followed by a second addition of enzyme at the time of addition of
BMP-7), Streptomyces hyaluronidase only for 24 h or no treatment for
24 h. After the treatments the cells were lysed with passive lysis buffer and
luciferase activity measured using the dual luciferase assay system (Promega).
pSV- -galactosidase control vector (Promega) activity was measured in all
experiments to normalize for transfection efficiency. Graph presented
shows mean value   SEM based on the analysis of triplicate wells from
three experiments.
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